Hemolysis assay |
All devices except those that do not have direct contact with blood cells |
Measures the damage to red blood cells when exposed to materials or their extracts and compares it to positive and negative controls. |
Coagulation assays |
All devices with blood |
Measures the effect of the test article on human blood coagulation time. |
Prothrombin Time Assay |
All devices with blood |
General screening test for the detection of coagulation abnormalities in the extrinsic pathway. |
Partial Thromboplastin Time Assay |
All devices with blood |
Detects coagulation abnormalities in the intrinsic pathway. |
Thrombogenicity test |
Devices unsuited to in vivo |
Required tests in coagulation, platelets, hematology, and complement system categories. The most common test for thrombogenicity is the in vivo method. |
Complement activation |
Implant devices |
In vitro assay to measure complement activations in the human plasma due to exposure of the plasma to the test article or an extract. Measures complement activation. |